Stone X Group Inc. Bio Restorative Therapies, Inc. Transaction History

Stone X Group Inc.

$2.29 Trillion
Q3 2025

A detailed history of Stone X Group Inc. transactions in Bio Restorative Therapies, Inc. stock. As of the latest transaction made, Stone X Group Inc. holds 37,450 shares of BRTX stock, worth $49,808. This represents 0.0% of its overall portfolio holdings.

Number of Shares

37,450

Previous 37,744 0.78%

Holding current value

$49,808

Previous $62.9 Million 13.62%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 14, 2025	SELL	$1.41 - $1.84 $414 - $540	-294 Reduced 0.78%	37,450 $54.3 Million
Q2 2025 Aug 13, 2025	BUY	$1.55 - $2.0 $58,503 - $75,488	37,744 New	37,744 $62.9 Million
Q1 2025 Aug 13, 2025	BUY	$1.49 - $2.49 $1,563 - $2,612	1,049 Added 2.09%	51,192 $91.1 Million
Q1 2025 May 15, 2025	BUY	$1.49 - $2.49 $1,627 - $2,719	1,092 Added 2.18%	51,192 $91,000
Q4 2024 Aug 13, 2025	SELL	$1.33 - $1.73 $3,173 - $4,127	-2,386 Reduced 4.54%	50,143 $71.7 Million

Q3 2024 Aug 13, 2025	SELL	$1.32 - $1.98 $5,797 - $8,696	-4,392 Reduced 7.72%	52,529 $91.4 Million
Q2 2024 Aug 13, 2025	BUY	$1.15 - $2.22 $6,588 - $12,718	5,729 Added 11.19%	56,921 $116 Million
Q2 2024 Aug 07, 2024	BUY	$1.15 - $2.22 $17,537 - $33,855	15,250 Added 43.76%	50,100 $102,000
Q1 2024 Aug 13, 2025	BUY	$1.28 - $3.45 $14,041 - $37,846	10,970 Added 45.94%	34,850 $48.1 Million
Q1 2024 May 01, 2024	BUY	$1.28 - $3.45 $44,608 - $120,232	34,850 New	34,850 $48,000
Q4 2023 Aug 13, 2025	SELL	$1.74 - $2.28 $47,522 - $62,271	-27,312 Reduced 53.35%	23,880 $41.5 Million
Q3 2023 Aug 13, 2025	SELL	$1.45 - $4.57 $39,602 - $124,815	-27,312 Reduced 53.35%	23,880 $42.7 Million
Q3 2023 Nov 14, 2023	BUY	$1.45 - $4.57 $13,050 - $41,130	9,000 Added 60.48%	23,880 $43,000
Q2 2023 Aug 13, 2025	SELL	$3.49 - $6.49 $237 - $441	-68 Reduced 0.45%	14,886 $65.6 Million
Q2 2023 Aug 11, 2023	SELL	$3.49 - $6.49 $258 - $480	-74 Reduced 0.49%	14,880 $66,000
Q1 2023 Aug 13, 2025	SELL	$2.67 - $3.61 $9,032 - $12,212	-3,383 Reduced 18.45%	14,954 $50.8 Million
Q4 2022 Aug 13, 2025	SELL	$2.58 - $3.68 $84,765 - $120,906	-32,855 Reduced 64.18%	18,337 $50.4 Million
Q1 2022 Aug 13, 2025	SELL	$3.3 - $5.69 $119,585 - $206,194	-36,238 Reduced 70.79%	14,954 $78.2 Million
Q1 2022 Aug 13, 2025	SELL	$3.3 - $5.69 $119,585 - $206,194	-36,238 Reduced 70.79%	14,954 $78.2 Million
Q4 2021 Aug 13, 2025	SELL	$4.02 - $18.0 $145,676 - $652,284	-36,238 Reduced 70.79%	14,954 $64,000
Q4 2021 Feb 10, 2022	BUY	$4.02 - $18.0 $60,115 - $269,172	14,954 New	14,954 $65,000

Others Institutions Holding BRTX

# of Institutions

Shares Held

397K

Call Options Held

Put Options Held

View Full List

About BioRestorative Therapies, Inc.

Ticker BRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 3,650,030
Market Cap $4.85M
Description
BioRestorative Therapies, Inc., a life sciences company, focuses on the development of regenerative medicine products and therapies using cell and tissue protocols primarily involving adult stem cells. The company's two core developmental programs relate to the treatment of disc/spine disease and metabolic disorders. Its disc/spine program (brtx...

More about BRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Stone X Group Inc., based on Form 13F filings with the SEC.

News

Stay updated on Stone X Group Inc. with notifications on news.

Account